Medical device registry for Medtronic neurovascular products
Part of Brain & nervous system, Heart & circulation clinical trials.
This study follows people who receive a specific Medtronic neurovascular device to learn about safety and performance over time. It may help improve how these devices are used and monitored in real-world care.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You (or your legal representative) can give consent and sign the study forms required by your hospital and location
- You have been treated with, or plan to be treated with, an eligible Medtronic neurovascular product
- You are at least 18 years old at the time you enroll (adult consent rules)
- You can be reached for follow-up visits or check-ins during the study
- You are not currently in, and do not plan to join, another drug or device study that could affect the results
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This is a follow-up registry that collects information from people who have (or will receive) an eligible Medtronic device. It helps the company and doctors better understand how the device works in real-world use.
This study collects information from routine medical care to learn how well MicroVention devices work in real-world settings for people being treated for brain aneurysms or stroke from a blocked artery. Your doctor has already decided to use one of these devices as part of your standard treatment.
This study is a registry that collects information from patients who have had a brain aneurysm treated with a special type of device called a flow diverter or flow disruptor. By joining, you help doctors learn more about how well these treatments work over time and which patients benefit most.
This post-marketing study follows people after they receive Balt medical devices to make sure the devices are safe, work well, and are easy to use in real life. You may be considered if you can consent and your procedure matches their device-use rules.
This trial tests a new device called the World Diverter Embolization Device to treat brain aneurysms (a weak spot in a blood vessel that can bulge or burst). The device is placed inside the artery to block blood flow into the aneurysm. This study checks if the device is safe and works well.
This registry tracks how Medtronic's FDA-approved devices work in treating acute ischemic stroke (a type of stroke caused by a blood clot) in everyday clinical practice. Researchers collect information to understand device safety and effectiveness outside of formal clinical trials.
Hear when a new Intracranial Aneurysm trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.